In8bio, Inc (INAB) insider trading

Every open-market stock purchase and sale by In8bio, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Leslie W. Kreis (10% owner), $115, 17 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent INAB insider trades

DateInsiderTradeValue
May 27, 2026Emily Fairbairn (Insider)Sold (not open market)—
May 9, 2026Kate Rochlin (COO)Bought (not open market)—
May 9, 2026Corinne Epperly (Insider)Bought (not open market)—
May 9, 2026Emily Fairbairn (Insider)Bought (not open market)—
May 9, 2026William Tai-Wei Ho (CEO)Bought (not open market)—
May 9, 2026Jeremy R. Graff (Insider)Bought (not open market)—
May 9, 2026Lawrence Lamb (C-suite exec)Bought (not open market)—
May 9, 2026Patrick McCall (CFO)Bought (not open market)—
May 9, 2026Peter C. Brandt (Insider)Bought (not open market)—
May 9, 2026Luba Greenwood (Insider)Bought (not open market)—
Feb 4, 2026Lawrence Lamb (C-suite exec)Bought (not open market)—
Feb 4, 2026William Tai-Wei Ho (CEO)Bought (not open market)—
Feb 4, 2026Kate Rochlin (COO)Bought (not open market)—
Feb 4, 2026Patrick McCall (CFO)Bought (not open market)—
Dec 22, 2025Emily Fairbairn (Insider)Bought (not open market)$1M
Dec 22, 2025Peter C. Brandt (Insider)Bought (not open market)$100K
Dec 22, 2025William Tai-Wei Ho (CEO)Bought (not open market)$50K
Dec 22, 2025Alan S. Roemer (Insider)Bought (not open market)$50K
Dec 22, 2025Patrick McCall (CFO)Bought (not open market)$10K
Dec 22, 2025Kate Rochlin (COO)Bought (not open market)$10K

Who's trading INAB

Get free alerts when an insider at In8bio, Inc files a new trade →